A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2011
10/19/2011	CN102224169A Polypeptides, antibody variable domains & antagonists
10/19/2011	CN102219859A Fusion protein for antagonizing angiogenesis inducible factor and application thereof
10/19/2011	CN102218145A Medicinal composition for protecting optic nerve of glaucoma and preparation method thereof
10/19/2011	CN102218121A Health care traditional Chinese medicine for people being in contact with computers and watching televisions
10/19/2011	CN102218115A Health care traditional Chinese medicine for drivers
10/19/2011	CN102218083A Drug composition for treating and preventing ophthalmic diseases
10/19/2011	CN102218051A Application of sodium valproate in preparation of medicament for treating or improving optic nerve pathological changes of glaucoma
10/19/2011	CN102217980A Preparation method for rhesus monkey choroids angiogenesis models
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN101904819B Method for preparing taurine particles
10/19/2011	CN101884715B Medicament for treating optic neuritis and preparation method thereof
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039482 Composition of solifenacin or salt thereof for use in solid formulation
10/18/2011	US8039464 Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases
10/18/2011	US8039010 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders
10/18/2011	CA2579207C Morpholine compound
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2466906C Pharmaceutical composition comprising a prostaglandin e1
10/18/2011	CA2462345C Dimeric compounds and their use as anti-viral agents
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2213833C Vascular endothelial cell growth factor antagonists
10/13/2011	WO2011127221A1 Gamma-polyglutamic acid-based ocular irrigating solutions
10/13/2011	WO2011127196A1 Ketorolac compositions for corneal wound healing
10/13/2011	WO2011124571A1 Pharmaceutical compositions highly dosed with biotin
10/13/2011	WO2011071995A9 Compounds and methods of treating ocular disorders
10/13/2011	WO2011068786A9 Treating xerophthalmia with compounds increasing meibomian gland secretion
10/13/2011	US20110251285 Combinations of preservatives for ophthalmic compositions
10/13/2011	US20110251283 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/13/2011	US20110251274 Natural Vitamin E Compositions with Superior Antioxidant Potency
10/13/2011	US20110251260 NOVEL siRNAS AND METHODS OF USE THEREOF
10/13/2011	US20110251253 Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251220 Pharmaceutical compositions comprising gamma secretase modulators
10/13/2011	US20110251207 Biaryl-spiroaminooxazoline analogues as alpha 2c adrenergic receptor modulators
10/13/2011	US20110251201 Sustained release intraocular implants and methods for preventing retinal dysfunction
10/13/2011	US20110251195 Adrb2 gene polymorphism associated with intraocular pressure response to topical beta-blockers
10/13/2011	US20110251182 Agents and methods for treating ischemic and other diseases
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251166 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/13/2011	US20110251165 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/13/2011	US20110251151 Combination compositions for reducing intraocular pressure
10/13/2011	US20110251137 Gamma-polyglutamic acid-based ocular irrigating solutions
10/13/2011	US20110250285 Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
10/13/2011	US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	CA2796071A1 Ketorolac compositions for corneal wound healing
10/13/2011	CA2795699A1 Punctal plugs for controlled release of therapeutic agents
10/13/2011	CA2795465A1 Pharmaceutical compositions highly dosed with biotin
10/13/2011	CA2794563A1 Gamma-polyglutamic acid-based ocular irrigating solutions
10/12/2011	EP2374472A2 Compositions and methods for treating ophthalmic disorders
10/12/2011	EP2374451A2 Histone deacetylase inhibitors (HDAC) that correct protein misfolding and uses thereof
10/12/2011	EP2373304A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/12/2011	EP2107052B1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/12/2011	EP1538888B1 Upper hitch link
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216318A Antioxidant
10/12/2011	CN102216317A Antioxidant
10/12/2011	CN102215842A Therapeutic agent for chorioretinal degenerative diseases comprising pyridine-3-carbaldehyde o-(piperidin-1-yl-propyl)-oxime derivative as active ingredient
10/12/2011	CN102212596A Preparation method of human epidermal growth factor
10/12/2011	CN102212093A Flavonoid glycoside compounds, method for preparing same and application
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210864A Formula of medicament for treating non-infectious ocular inflammations, and inhibiting corneal neovascularization and anti-rejection reaction generated after corneal grafting
10/12/2011	CN102210856A Collagen eye drops and preparation method thereof
10/12/2011	CN102210851A Application of human alpha b crystalline protein in preparing medicament for protecting retinal ganglion cells
10/12/2011	CN102210849A Preparation of cyclosporine A nano-particle eye drop
10/12/2011	CN102210841A Chinese medicinal preparation for treating central serous retinopathy
10/12/2011	CN102210821A Traditional Chinese medicine for treating xerophthalmia
10/12/2011	CN102210739A Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof
10/12/2011	CN102210684A Application of ectoine and derivants thereof in preparation of medicament for treating cataract
10/12/2011	CN102210683A Application of tetrahydropyrimidine and derivatives thereof in preparing medicament for preventing and treating glaucoma
10/12/2011	CN102210672A Application of polyketide in preparation of angiogenesis inhibiting medicine
10/12/2011	CN102210648A High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
10/12/2011	CN102210645A Lutein ophthalmic nanocapsule in-situ gel preparation and preparation method thereof
10/12/2011	CN101703625B Oral Chinese medicinal composition for treating glaucoma
10/12/2011	CN101496808B Compound xanthophyll microcapsule for sight protection and preparation method thereof
10/12/2011	CN101317921B Externally washing medicament for treating external hordeolum
10/12/2011	CN101306143B Ear drops for treating otitis media suppurativa acuta
10/12/2011	CN101199847B Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof
10/12/2011	CN101160139B Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034803 Photodynamic therapy of occult age-related macular degeneration
10/11/2011	US8034799 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/11/2011	US8034615 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
10/11/2011	US8034366 Poly lactic co-glycolic acid copolymer biodegradable polymer matrix; eye implant infused with ace-inhibitors, endogenous cytokines, agents that influence basement membrane, agents that influence the growth of endothelial cells, adrenergic agonists or blockers; uveitis, macular edema, macular degeneration
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/06/2011	WO2011122872A2 Composition comprising coumestrol or a bean extract containing coumestrol
10/06/2011	WO2011122458A1 Aromatic ring compound containing nitrogen
10/06/2011	WO2011122321A1 Agent for inhibiting physiological activity of heparin-binding protein
10/06/2011	WO2011063005A3 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245319 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
10/06/2011	US20110245297 Use Quaternary Pyridinium Salts as Vasoprotective Agents
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245250 Potassium ion channel modulators & uses thereof

1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 531